{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:35:31Z","timestamp":1784547331540,"version":"3.55.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"62","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.18632\/oncotarget.22523","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T10:58:01Z","timestamp":1511175481000},"page":"106026-106037","source":"Crossref","is-referenced-by-count":31,"title":["RTL1 promotes melanoma proliferation by regulating Wnt\/\u03b2-catenin signalling"],"prefix":"10.18632","volume":"8","author":[{"given":"Guobiao","family":"Fan","sequence":"first","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"},{"name":"Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Tongji University, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ye","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songcheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Xi","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Guo","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qiao","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jia","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohuang","family":"Fan","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Kang","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Health Hospital, Shanghai Key Laboratory of Signalling and Disease Research, Collaborative Innovation Center for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Sober","year":"2004","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.05708.x","article-title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","volume":"150","author":"Dawes","year":"2004","journal-title":"Br J Dermatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights","volume":"9","author":"Hoiom","year":"2016","journal-title":"Appl Clin Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1470-2045(12)70373-X","article-title":"Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study","volume":"13","author":"Tonini","year":"2012","journal-title":"Lancet Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2014.02.035","article-title":"Ipilimumab in patients with cancer and the management of dermatologic adverse events","volume":"71","author":"Hauschild","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"7","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","article-title":"Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center","volume":"33","author":"Chapman","year":"2015","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cmet.2012.01.006","article-title":"Imprinted gene dosage is critical for the transition to independent life","volume":"15","author":"Ferguson-Smith","year":"2012","journal-title":"Cell Metab"},{"key":"9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ng.2007.51","article-title":"Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta","volume":"40","author":"Ishino","year":"2008","journal-title":"Nat Genet"},{"key":"10","doi-asserted-by":"crossref","first-page":"e26693","DOI":"10.4161\/mge.26693","article-title":"Domesticated transposable element gene products in human cancer","volume":"3","author":"Dupuy","year":"2013","journal-title":"Mob Genet Elements"},{"key":"11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4161\/15384047.2014.986944","article-title":"Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers","volume":"16","author":"Cao","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"12","doi-asserted-by":"crossref","first-page":"e1003441","DOI":"10.1371\/journal.pgen.1003441","article-title":"Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis","volume":"9","author":"Dupuy","year":"2013","journal-title":"PLoS Genet"},{"key":"13","first-page":"2251","article-title":"Altered expression of imprinted genes in squamous cell carcinoma of the head and neck","volume":"36","author":"Yang","year":"2016","journal-title":"Anticancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","article-title":"Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway","volume":"22","author":"Costantini","year":"2002","journal-title":"Mol Cell Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.0022-202X.2004.23460.x","article-title":"Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling","volume":"123","author":"Fabra","year":"2004","journal-title":"J Invest Dermatol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Nusse","year":"2012","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/3957","article-title":"The Wnt signaling pathways and cell adhesion","volume":"17","author":"Vincan","year":"2012","journal-title":"Front Biosci"},{"key":"18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1365-2133.2002.47322.x","article-title":"Loss of beta-catenin expression is associated with disease progression in malignant melanoma","volume":"146","author":"Osborne","year":"2002","journal-title":"Br J Dermatol"},{"key":"19","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.18632\/oncotarget.2512","article-title":"SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt\/beta-catenin pathway","volume":"5","author":"Han","year":"2014","journal-title":"Oncotarget"},{"key":"20","doi-asserted-by":"crossref","first-page":"34658","DOI":"10.1074\/jbc.M113.500314","article-title":"Protein kinase PKN1 represses Wnt\/beta-catenin signaling in human melanoma cells","volume":"288","author":"Moon","year":"2013","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"publisher","first-page":"43295","DOI":"10.18632\/oncotarget.9232","article-title":"The role of Wnt\/beta-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines","volume":"7","author":"Bellei","year":"2016","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/bjc.2016.332","article-title":"In the Wnt-er of life: Wnt signalling in melanoma and ageing","volume":"115","author":"Weeraratna","year":"2016","journal-title":"Br J Cancer"},{"key":"23","first-page":"e11","article-title":"A Wnt-er migration: the confusing role of beta-catenin in melanoma metastasis","volume":"6","author":"Weeraratna","year":"2013","journal-title":"Sci Signal"},{"key":"24","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2012.229","article-title":"Beta-catenin inhibits melanocyte migration but induces melanoma metastasis","volume":"32","author":"Larue","year":"2013","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2014.04.012","article-title":"Targeting the beta-catenin nuclear transport pathway in cancer","volume":"27","author":"Henderson","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-9-64","article-title":"Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer","volume":"9","author":"Shieh","year":"2010","journal-title":"Mol Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"e95136","DOI":"10.1371\/journal.pone.0095136","article-title":"Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells","volume":"9","author":"Brodin","year":"2014","journal-title":"PLoS One"},{"key":"28","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.4161\/cc.20765","article-title":"The tumor suppressor HINT1 regulates MITF and beta-catenin transcriptional activity in melanoma cells","volume":"11","author":"Sgambato","year":"2012","journal-title":"Cell Cycle"},{"key":"29","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1038\/ncomms7156","article-title":"Tumour suppressor TRIM33 targets nuclear beta-catenin degradation","volume":"6","author":"Huang","year":"2015","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/jcb.24803","article-title":"Factors affecting the nuclear localization of beta-catenin in normal and malignant tissue","volume":"115","author":"Darley","year":"2014","journal-title":"J Cell Biochem"},{"key":"31","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.06619-11","article-title":"Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling","volume":"32","author":"Becker","year":"2012","journal-title":"Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.25086","article-title":"Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer","volume":"127","author":"Barany","year":"2010","journal-title":"Int J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1172\/JCI62980","article-title":"MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth","volume":"123","author":"Kallenberg","year":"2013","journal-title":"J Clin Invest"},{"key":"34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5999\/aps.2013.40.3.238","article-title":"Surgical options for malignant skin tumors of the hand","volume":"40","author":"Kwon","year":"2013","journal-title":"Arch Plast Surg"},{"key":"35","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/onc.2011.427","article-title":"NF-kappaB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the beta-catenin pathway","volume":"31","author":"Richmond","year":"2012","journal-title":"Oncogene"},{"key":"36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","article-title":"Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism","volume":"108","author":"He","year":"2002","journal-title":"Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrclinonc.2014.36","article-title":"Melanoma: smart therapeutic strategies in immuno-oncology","volume":"11","author":"Robert","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Hayward","year":"2012","journal-title":"N Engl J Med"},{"key":"39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature10662","article-title":"RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)","volume":"480","author":"Tadi","year":"2011","journal-title":"Nature"},{"key":"40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Lawrence","year":"2012","journal-title":"N Engl J Med"},{"key":"41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00280-013-2324-5","article-title":"A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma","volume":"73","author":"Daud","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ncomms1727","article-title":"Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance","volume":"3","author":"Long","year":"2012","journal-title":"Nat Commun"},{"key":"43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"McArthur","year":"2010","journal-title":"Nature"},{"key":"44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.01.008","article-title":"Mutant BRAF melanomas--dependence and resistance","volume":"19","author":"Rosen","year":"2011","journal-title":"Cancer Cell"},{"key":"45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jid.2017.01.021","article-title":"AURKA overexpression is driven by FOXM1 and MAPK\/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy","volume":"137","author":"Pujana","year":"2017","journal-title":"J Invest Dermatol"},{"key":"46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Gajewski","year":"2015","journal-title":"Nature"},{"key":"47","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Lo","year":"2015","journal-title":"Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:57:38Z","timestamp":1589209058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":47,"journal-issue":{"issue":"62","published-print":{"date-parts":[[2017,12,1]]}},"alternative-id":["22523","29285312"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22523","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}